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ABSTRACT 
 
Aims: To determine the total phenols content and antioxidant capacity for turmeric and curcumin, 
and to assess the effect of alpha-Linolenic acid (ALA) combinations treatments on MCF-7 breast 
cancer cell viability and intracellular reactive oxygen species (ROS).  
Study Design: In-vitro study. 
Place and Duration of Study: School of Biomedical Sciences, Ulster University, Coleraine (UK) 
September 2015 to September 2016. 
Methods: Curcumin was characterized for total phenols content (TPC) and antioxidant capacity 
(AOC) using Folin-Denis and ABTS (2,2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid 
diammonium salt) assays. MCF-7 cells were grown in DMEM phenol-red free medium (+ 10% 
charcoal stripped foetal bovine serum) and treated with curcumin, ALA or their combinations. 
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Cytotoxicity was assessed using the sulforhodamine-B assay. Intracellular ROS was monitored 
using 2,7-dichlorodihydroflourescein diacetate assay.  
Results: Curcumin showed 42-50 folds higher TPC and AOC compared to turmeric. Both curcumin 
and ALA (0-500 µM) inhibited MCF-7 cells with the 50% effective dose (EC50) equal to 32 µM 
(curcumin) or 117 µM (ALA). Combination of curcumin and ALA led to EC50 values of 221 µM 
(curcumin) and 304 µM (ALA). Isobologram analysis and values for Combination index (CI; CI>1.0) 
are consistent with ALA and curcumin antagonism. Changes of intracellular ROS were 20-fold 
higher with ALA treatment of MCF-7 compared with curcumin.  
Conclusions: ALA and curcumin were each cytotoxic towards MCF-7 breast cancer cells but their 
combination decreases the effectiveness of each agent due to antagonistic interactions. Both ALA 
and curcumin produce rises in intracellular ROS for MCF-7 cells. The wider implications of such 
findings is that though dietary antioxidants could be beneficial on their own, antagonistic interaction 
with ALA, n-3 fatty acids and other ROS generating conventional anti-cancer drug could be of 
concern. 
 
 
Keywords: Alpha-linolenic acid; curcumin; MCF-7 cells; cytotoxicity; isobologram. 
 
1. INTRODUCTION  
 
Breast cancer is the most common cancer 
among females in both developed and less 
developed countries [1]. The International 
Agency for Research on Cancer (IARC) reported 
1.6 million new cases of breast cancer worldwide 
in 2012, which is 25% of all cancer incidents [1]. 
About 70 - 75% of breast cancer is estrogen 
receptor and/or progesterone receptor positive 
[2]. Dietary polyunsaturated fatty acid (PUFA) 
may affect breast cancer risk by increasing 
endogenous estrogen levels. The presence of 
PUFA in adipose tissue may promote the 
conversion of androstenedione to estrone, inhibit 
estrogen binding to serum protein and 
consequently raise the circulating estrogen level. 
The type of PUFA and food source may affect 
breast cancer risk [2,3]. Alpha-Linolenic acid 
(ALA) is the primary omega-3 (n-3) PUFA 
consumed through food such as leafy 
vegetables, walnuts, soybeans, and flaxseed. 
Dietary ALA (18:3 n-3) is metabolised to 
eicosapentaenoic acid (EPA) (20:5 n-3), and 
docosahexaenoic acid (DHA) (22:6 n-3) through 
a sequence of desaturation and elongation steps 
[4]. PUFA were found to enhance chemotherapy 
and radiation treatments following lipid 
peroxidation to form cytotoxic products [5,6]. 
Antioxidants such as vitamin E, vitamin C and 
curcumin were found to decrease cancer cell 
apoptosis induced by lipid peroxidation products 
formed from PUFA [5-7]. 
 
Plant polyphenolic antioxidants such as curcumin 
from turmeric may reduce the incidence of major 
non-communicable diseases, including cancer [8, 
9]. Turmeric is a golden spice derived from 
Curcuma longa plant and used as a spice, 
colouring agent and in traditional medicine [8,9]. 
Curcumin accounts for 2-5% of dried weight of 
turmeric and its biological activity [8,9]. Previous 
research showed curcumin had anticancer 
effects on breast cancer cell lines, via a reduction 
of cell proliferation, induction of cell cycle arrest, 
modulating MicroRNA and promotion of 
apoptosis induced by reactive oxygen species 
(ROS) [10].  
 
ALA shows cytotoxicity to cancer cells due partly 
to its lipid peroxidation products [6,7]. The 
antioxidant characteristics of turmeric and 
curcumin were also confirmed independently 
[8.9] and curcumin was shown to inhibit the 
effectiveness of anticancer agents that induce 
cell apoptosis via ROS activation of JNK 
signalling [7]. The hypothesis tested in this study 
was that, combination treatments involving ALA 
and curcumin will reduce the cytotoxicity of each 
agent towards MCF-7 breast cancer cells. 
Phenol red-free culture media [11-14] was an 
important feature of the experimental design. The 
aims of this study were to investigate the effect of 
ALA and curcumin on breast cancer cell 
proliferation individually and in combination using 
phenol red-free medium, and to examine the 
effect of ALA and curcumin on the formation of 
intracellular ROS in MCF-7 cells. The design of 
this study was such that possible interaction 
could be explored to a greater degree than 
reported previously [15]. 
 
2. MATERIALS AND METHODS  
 
2.1 Materials  
 
Certified organic ground turmeric (haldi) powder 
produced by Hatton Hill Organic Ltd. (Enfield, 
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UK) was purchased from Rohan Foods Ltd. 
(London, UK). Curcumin powder (>98% pure) 
was purchased from Sigma-Aldrich (UK). 
Additional analytical grade reagents were 
purchased from Sigma-Aldrich (Gillingham, UK) 
and used as received. Phosphate buffered saline 
(PBS) was from Oxoid Ltd (Basingstoke, UK). 
 
2.2 Instrumentation 
 
Colorimetric measurements were recorded using 
a UV/ Visible spectrophotometer (Ultrospec 
2000, Pharmacia Biotech, Uppsala Sweden) in 
conjunction with 1-cm polystyrene cuvettes 
(Sarsted Ltd., Leicester, UK). All microplate 
assays involved a 96-microplate reader 
(VersaMax™ ELISA microplate reader, 
Molecular Devices, Sunnyvale, CA, USA.) used 
with flat-bottomed 96-well microplates (NUNC, 
Sigma Aldrich, UK). The florescence measured 
using BMG LABTECH microplate readers 
(FLUOstar® Omega, BMG LABTECH GmbH, 
Ortenberg, Germany) with black polystyrene 
plate (NUNC, F96 MicroWell black polystyrene 
plate, Thermo Fisher Scientific). 
 
2.3 Antioxidants Assays 
 
2.3.1 Material extractions  
 
Curcumin powder (36.84 mg) was dissolved in 
10 ml of dimethyl sulfoxide (DMSO) to prepare 
10 mM solution. To prepare turmeric extract 
36.84 mg of turmeric powder was stirred in 10 ml 
of DMSO for 60 minutes. Then 1ml of the mixture 
was transferred to 9 ml of distilled water. The 
final mixture was centrifuged to remove 
undissolved solids.  
 
2.3.2 Preparation of material extract dilutions 
 
Turmeric or curcumin extract was diluted using 
PBS or distilled water and examined for total 
phenolic content (TPC) and antioxidant capacity 
(AOC) as reported below. A number of dilutions 
were examined to achieve a linear absorbance 
range with each reference compound and also, 
to avoid formation of precipitation which result 
from adding concentrated extract to the assay 
system. 
 
2.3.3 Preparation of assay reference 
compounds 
 
The reference compounds for the calibration of 
TPC and antioxidant assays was gallic acid; for 
AOC analysis the reference was gallic acid, 
ascorbic acid or trolox. They were prepared from 
1000 µM solutions and diluted with PBS or 
distilled water to 500 µM, 250 µM and 125 µM, 
before use. All references were prepared daily 
before use.  
 
2.3.4 Evaluation of TPC using folin-denis 
method 
 
The Folin-Denis method was adapted from a 
previous report [16]. In brief, 50 µl of curcumin or 
turmeric solution (or diluted sample) was added 
to micro-centrifuge tubes, followed by 100 µl of 
Folin-Denis reagent and 850 µl of sodium 
carbonate (7.5% w/v) reagent. The tube contents 
were vortexed gently and incubated for 60 
minutes at 37˚C followed by 30 minutes at room 
temperature. The tubes were then centrifuged 
using bench top centrifuge (model 
MSB010.CX2.5, MSE, London, UK) at 11,000 
rpm (8793xg) for 5 minutes and 200 µl of 
supernatant were carefully transferred to 96-
microwell plates. The absorbance was measured 
at 760nm using a microplate reader. 
 
2.3.5 Evaluation of AOC  
 
Determination of AOC involved the 2,2′-Azino-   
bis (3-ethylbenzthiazoline-6-sulfonic acid 
diammonium salt; ABTS) assay [17] as described 
recently [18]. ABTS solution was prepared by 
dissolving 27.4 mg with 90 ml of PBS buffer. 
Sodium persulfate (20 mg) was dissolved with 
another 10 ml of PBS. The ABTS working 
solution was generated by mixing the previous 
two solutions and storing in the dark at room 
temperature for 12-16 hours. For sample 
analysis and calibration, ABTS working solution 
was diluted with PBS buffer in order to achieve 
an initial absorbance of 0.85 at 734 nm using 1 
cm spectrophotometer (standard colorimeter). 
Then, 20 µl of reference compounds (explained 
above) were added to micro-centrifuge tubes 
followed with 1.48 ml of ABTS solution. The 
resulting mixtures were incubated for 30 minutes 
at 37°C and 200 µl samples were transferred to 
96-microwell plates for absorbance readings at 
734 nm. Curcumin or turmeric solutions were 
pre-diluted in distilled water or PBS (dilution 
Factor (DF) = 10-1000) and analysed similarly. 
 
2.4 Cytotoxicity Assay 
 
2.4.1 Cell lines and maintenance of cell 
culture 
 
Estrogen receptor positive (ER+) MCF-7 breast 
cancer cells (American Type Culture Collection; 
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LGC Standards – Teddington, Middlesex, UK) 
were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; GIBCO) with 10% foetal bovine 
serum (FBS), 1% w/v penicillin streptomycin 
(Pen Strep) and 1% minimum essential medium 
non-essential amino acids (MEM NEAA). Culture 
flasks and 96-microwell plates were incubated in 
a humidified incubator at 37°C in O2 95% and 
CO2 5% (LEEC Research CO2 Incubator, LEEC 
Ltd., Nottingham, UK). Cells were washed with 
PBS three time, trypsinized, then transferred to 
phenol red free medium (DMEM F12 phenol free; 
GIBCO) with 10% protein charcoal stripped FBS, 
USDA-approved, 1% w/v penicillin streptomycin 
(Pen Strep) and 1% minimum essential medium 
non-essential amino acids (MEM NEAA). The 
trypsinized cells were counted using a 
NucleoCounter (NC-3000, ChemoMetec, Allerod, 
Denmark) and seeded in 96-microwell plates 
(10,000 cells/ well) with 50 µl of phenol-red free 
culture medium overnight to allow cell 
attachment. Cell viability was monitored using a 
sulforhodamine method (see below). 
 
2.4.2 Curcumin and ALA preparation for 
cytotoxicity studies 
 
Curcumin stock solutions were prepared as 
described in section 2.3. Alpha-Linolenic acid 
(ALA) was diluted in DMSO to make a 10mM 
stock solution. The stock solutions were diluted 
in phenol red-free culture medium, and cold-
sterilised using 0.20 µm cellulose acetate filters. 
Varying concentration of curcumin or ALA (0-500 
µM) in cell culture media were applied to the 
cells and incubated at 37°C for 3 days and 6 
days. The final concentration of DMSO in the 
treated wells was non-toxic to MCF-7 cells (less 
than 1%) [15]. In the control study, cells were 
treated with culture medium only. For the 
combination studies, cells were treated with a 
range of ALA (0 – 500 µM) or curcumin (0 – 500 
µM) but in the presence of a fixed concentration 
of the second agent as described in ref [19].   
 
2.4.3 Assessing cell viability using 
sulforhodamine B (SRB) assay  
 
The SRB assay is a colorimetric assay to 
measure cell numbers by detecting cell proteins 
[20]. After curcumin or ALA treatments, the cells 
were fixed with 100 µl of cold 10% (w/v) 
trichloroacetic acid and incubated at 5°C for 60 
minutes. Then, the microplates were washed 
with tap water four times and allowed to air-dry. 
After that, the cells were stained with 100 µl per 
well of 0.06% SRB dye solution (1% w/v in acetic 
acid) for 30 minutes at room temperature. The 
cells were rinsed four times with 100 µl per well 
of 1% (v/v) acetic acid to remove unbound stain. 
When the plates were dried, Trizma-base (200 
µl/well, 10 mM) was added to solubilise SRB 
dye, and the plate was shaken for 5 minutes on 
an orbital shaker at speed of 180 revs/min. 
Finally, the absorbance was measured using a 
plate reader at 564 nm. 
 
2.5 Determination of Intracellular ROS 
Using 2, 7-dichlorodihydroflourescein 
Diacetate (DCFH-DA) Assay  
 
The DCFH-DA assay is for assessing 
intracellular ROS. The assay was performed 
according to previous reports [21] with slight 
modification. In brief, a stock solution of DCFH-
DA was made by dissolving 10 mg of DCFH-DA 
powder into 1 ml DMSO. The working solution 
was prepared by diluting 49 µl of DCFH-DA stock 
solution with 20 ml of Hanks salt solution and 
filter sterilizing with 0.20 µm cellulose acetate 
filters. MCF-7 cells used for ROS testing were 
seeded in 96-wells plate and allowed to attach 
overnight. The cells were washed using Hanks 
salt solution (200 µl x1) and treated with DCFH-
DA working solution (50 µl). After 45 minutes’ 
incubation at 37°C, the cells were washed with 
phenol red-free culture medium (200 µl) and then 
treated with various concentrations (0.5-500 µM) 
of ALA or curcumin and also the combinations 
ALA and curcumin determined from the single 
treatment studies. Then, the plates were 
incubated at 37°C for 60 minutes, and 
fluorescence was measured at 485 nm 
(excitation) and 520 nm (emission) wavelengths 
on a microplate reader. 
 
2.6 Data Analysis 
 
2.6.1 TPC and AOC calibration graphs 
 
Absorbance readings for reference compounds 
were exported to Microsoft Office Excel software 
for graphing and analysing. Calibration graphs 
were constructed by plotting absorbance versus 
the concentration of references compounds in 
the assay system (M) on the x-axis. Data points 
were fitted with a linear regression trend line (y= 
x. GRAD) and apparent molar absorptivity 
(GRAD) was determined from the graph slope as 
described before [15,18]. 
 
2.6.2 TPC and AOC calculations from 
spectrophotometric data 
 
The TPC and AOC of turmeric and curcumin 
were determined using the formula [15,18];  
TPC or AOC = 
 

 
∗
 
	
  
∗  D ∗  

  
  10
 
where ∆A is the absorbance change corrected 
for the reagent blank, Av is the  total assay 
volume (1000 µl),   is the sip volume (50
sample analysed,   is the concentration of 
turmeric or curcumin solutions (g/l), D
undiluted solutions = 1, and GRAD is the slope 
obtained from gallic acid and/or ascorbic acid 
and trolox calibration graphs; the results are 
expressed as g/100 g DW using gallic acid 
equivalent (GAE), ascorbic acid equi
(ASC:), trolox equivalent (TE). The AOC values 
with trolox are cited as trolox equivalent 
antioxidant capacity (TEAC) [17,18].
  
2.6.3 Cell viability and statistical analysis
 
Cells viability experiments were repeated on 2 
different occasions with 12-24 replications per 
drug concentration. Microsoft Office Excel 
software was used for primary data operation 
and percentage of cell viability (CV%) calculation 
according to formula (2) below [15,18]; 
 
CV (%) =  
(A – A medium) *100 / (A control – A medium
 
where A= absorbance for cells treated with 
curcumin/ ALA, A medium = absorbance for the 
culture medium, A control = absorbance of cells 
treated with culture medium [15,18]. The results 
were expressed as mean ± SD, and statistically 
significant differences were determined by 1
Fig. 1. Calibration graphs for total phenol content and antioxidant capacity assays
TPC, GAE= Total phenol content with gallic acid as reference. ABTS, GAE = antioxidant capacity with gallic acid 
reference, ASC= ascorbic acid or TE= trolox
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F for 
valent 
 
 
 
) *100     (2) 
-way 
ANOVA using IBM SPSS v22. Post
for separation of means was by Tukey’s test. 
Probability values (P) less than 0.05 were 
considered to be statistically significant. Paired t
test were performed on a calculator at 
www.graphpad.com to test statistically signi
differences between EC50 (half maximal 
effective dose of treatment compound) values.
 
3. RESULTS  
 
3.1 TPC and AOC for Turmeric and 
Curcumin 
 
Fig. 1 shows the calibration graph for TPC and 
AOC determination using the Folin
ABTS assays, respectively. In TPC the reference 
compound was gallic acid. In the ABTS assa
three reference compounds were used, Gallic 
acid, ascorbic acid and trolox. Each reference 
compound had a linear response with a 
coefficient of regression (R2) >0.97. The data 
were fitted with a straight line equation (Y = x. 
GRAD), where Y= absorbance, x= concentration 
of reference agents, and GRAD = slope of the 
line. 
 
Table 1 compares TPC and antioxidant capacity 
for curcumin and turmeric in terms of 100g of dry 
weight. The value for TPC for curcumin was 
approximately 50 times higher than turmeric. 
Similarly, in the antioxidant capacity, curcumin 
was 42 times higher in equivalent to gallic acid 
and 5 times higher in equivalent of ascorbic acid 
and trolox (Table 1).  
 
 as references 
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3.2 Cell Viability Changes with ALA or 
Curcumin 
 
Phenol red is a pH indicator added frequently to 
cell culture media [11-14]. However, phenol red 
can also acts as an antioxidant, a weak estrogen 
receptor stimulator, a promotor for MCF-7 
proliferation and enhancer of cell stability against 
chemotherapy at neutral or low pH [12,13]. 
Interestingly, phenol red was also found to be 
cytotoxic towards MCF-7 cells at high 
concentrations and at pH 7.6-8.0 [14]. In the 
present study, phenol red-free media was used 
to avoid possible interferences in cell-based 
assays. Fig. 2 shows the treatment of MCF-7 
cells with ALA (0.005-5 µM) for 3 days led to 
significant increases in cell viability compared to 
the non-treated cells. However, cell viability 
decreased significantly at higher ALA (50-500 
µM) concentrations. With 6-days treatment cell 
viability remained stable and an inhibitory effect 
was observed at 50 – 500 µM of ALA. The dose 
of ALA necessary to reduce cell viability by 50% 
(EC50) with 3 and 6-days treatments is shown in 
Table 2. 
 
Fig. 3 shows that the treatment of MCF-7 cells 
with curcumin for 3 or 6 days produced no 
significant changes in cell viability at the 
concentration of 0.005-5 µM compared to the 
non-treated cells. However, cell viability 
decreased at 50 – 500 µM. The effective dose of 
curcumin for 50% inhibition (EC50) value 
decreased from 3-days to 6-days treatment, 32 
to 26 µM, respectively. The summary of EC50 
values for curcumin and for curcumin 
combination studies is provided in Table 2. 
 
Table 2. Potency of ALA, curcumin and their 
combinations for MDA-MB-231 cell inhibition 
expressed as EC50 
 
Treatment  EC50 
(3 days) 
EC50 
(6 days) 
ALA  117±11.0*A 62±4.3B 
Curcumin 32±3.6*C 26±2.7D 
ALA+ Curcumin (16 µM)⊥ 304±41.0  
Curcumin + ALA  
(100 µM)⊥ 
221±2.8*  
ALA = alpha Linolenic acid, EC50 = dose for 50% 
effectiveness, (Θ) SEM= standard error of mean.  
N = 24 data points from two independent studies. 
Rows and columns with different letters are 
significantly different (P = 0.05). ⊥ Combination studies 
(see text for details) 
 
3.2.1 Combination studies 
 
When cells were treated with a range of ALA 
concentrations and a fixed curcumin (16 uM) 
combination, the experimental EC50 value was 
304 µM which is significantly higher than the 
value of 117 µM (P= 0.0415) for treating cells 
with ALA alone (Table 2). Similarly, when cells 
were treated with curcumin in combination with 
ALA (fixed 100 µM) for 3 days the experimentally 
observed EC50 for curcumin increased by nearly 
7-fold compared to the EC50 for curcumin 
treatment alone (P = 0.0001). The results                    
for combination studies are summarized in              
Table 2. 
 
 
 
Fig. 2. Effect of α-linolenic acid (ALA) and its combination with curcumin on MCF-7 cell 
viability 
MCF-7 cells were treated with 0-500 um ALA + fixed curcumin (16 µM). Bars show mean +/- SEM. Within each 
panel different letters indicate statistical significant differences (P<0.05) 
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Fig. 3. Effect of curcumin and its combination with ALA on MCF-7 cell viability 
MCF-7 cells were treated with 0-500 µM curcumin or curcumin + fixed ALA (100 µM). Bars show mean +/- SEM. 
Within each panel different letters indicate statistical significant differences (P<0.05) 
 
An isobologram analysis was conducted to 
determine iso-effective concentrations of ALA 
plus curcumin which would produce the same 
effects as each component alone, assuming 
there were neither synergistic nor antagonistic 
interactions. The analysis involved eq. (3) 
adapted from reference [19];  
 
d50ALA =  α 117 (µM)    
d50CURC = (1-α) 32.6 (µM)                        (3) 
 
where α= fraction of ALA in a mixture, 1-α is the 
fraction of curcumin, d50ALA and d50CURC are 
the iso-effective concentrations of ALA or 
curcumin which when mixed will produce 50% 
cell growth inhibition. Fig. 4 shows the 
isobologram for ALA and curcumin. 
 
 
 
Fig. 4. Isobologram for alpha-linolenic acid 
(ALA) and curcumin (CURC) mixtures 
Graph shows iso-effective doses of two agents 
required for 50% inhibition of MCF-7 cell growth under 
present conditions of study. d50ALA and d50CURC are 
iso-effective concentrations of ALA or curcumin, 
respectively (see text for details) 
The continuous line from Fig. 4 shows the iso-
effective doses for ALA and curcumin. From              
Fig. 4, it can be seen that the EC50 value for 
ALA and curcumin are 117 and 32 µM, when 
used alone. However, combination treatments 
are predicted to decrease the effective dose for 
each agent. For example, a combination 
treatment using 16 µM curcumin and 58 µM ALA 
is predicted to achieve the same (50%) inhibition 
of MCF-7 cells inhibition as 117 µM ALA or 32 
µM curcumin used each on their own. An 
alternative interpretation of information from Fig. 
4 is that the 50% effective dose for ALA should 
be 58 µM in the presence of 16 µM curcumin            
(cf. dotted line in Fig. 4). The predictions can be 
contrasted with the experimentally observed 
EC50 value from the ALA combination study 
(d50ALA) of 304 µM (Table 2).   
 
The nature of interactions between ALA and 
curcumin were also evaluated in terms of a 
combination index (CI) defined from the relation 
below [19]; 
 
   
 !"#
$%
& 
 !"'
$%(
             (4) 
 
where, d50ALA and d50CURC refer to 
experimental EC50 values from combination 
studies, and EC501 and EC502 are values for 
each agent alone; CI < 1.0 is indicative of 
synergism, CI=1 indicates no interactions, CI 
>1,0 shows antagonism. As an illustration the 
combination study for ALA (with curcumin fixed) 
yields CI = (304/117) + (16/32) = 3.0. A similar 
treatment from the curcumin combination study 
shows, CI = 5.0.  In both cases CI >1.0 and such 
results are indicative of antagonism between 
these agents [19]. 
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Fig. 5. Effect of curcumin and α-linolenic acid and curcumin on intracellular ROS level in  
MCF-7 cells 
MCF-7 treated with curcumin, ALA (0.5-500 µM) or a combination of both 500 µM for 1 hour. Bars show mean +/- 
SEM. Bars with different letters indicate statistical significant differences between all groups, tested by ANOVA 
(P<0.05).  ALA= alpha-Linolenic acid 
 
3.3 Intracellular ROS Level 
 
The intracellular ROS levels for MCF-7 cells 
treated with curcumin and/ or ALA are shown in 
Fig. 5. When cells were treated with 0.5µM of 
ALA there was a 20- fold greater increases in 
ROS compared with increase seen with 
curcumin. At concentrations of 5-500 µM there 
was a surprising drop in ROS compared to 
values at 0.5 µM. The combination of curcumin 
and ALA resulted in a slight increase of ROS 
level relative to 500µM curcumin individually but 
not relative to the ROS level produced by 500 
µM ALA. 
 
4. DISCUSSION 
 
In a prior investigation we demonstrated that the 
anticancer effect of ALA towards MCF-7 cells 
was lower in the presence of antioxidant extracts 
[15]. The current study reassessed this issue, 
using phenol red-free medium and combination 
treatments designed to allow quantitative 
analysis of interactions. As part of the current 
study, we also assessed the TPC and AOC of 
curcumin and turmeric. Previous literature values 
for TPC or AOC of turmeric indicated a range of 
values probably because of differences the 
solvent used for extraction [22,23].  
 
For two varieties of Curcuma longa dried rhizome 
extracted with 80% aqueous methanol, the TPC 
was 2.13-2.16 g GAE/100 DW [22] and AOC 
determined using the ABTS assay was 18-22 
mmol TEAC/100 g DW [22]. Curcuma longa 
dried rhizome extracted with 80% aqueous 
ethanol showed TPC of 1.72±0.12 g GAE/100 g 
DW and AOC of 19.5±0.45 mmol TEAC/100 g 
DW [23]. Another study also found the TPC for 
Curcuma longa was 0.497 - 0.746 g GAE/100 g 
DW when using alcohol/water mixtures as 
extraction solvent [24]. For comparison, the 
turmeric sample in this study had TPC of 3 g 
GAE/100 g DW (Table 1) in agreement with 
previous reports, whilst the AOC using DMSO as 
extraction solvent was ~10 fold higher than 
reported previously.   
 
Curcumin dissolved with methanol had a TPC 
ranging from 8.7 g GAE/100 g DW [15] to 11.5 g 
GAE/100 g [25] and AOC was 23.4 mmol 
TEAC/100 g DW [15]. By comparison the current 
study shows ~20 fold higher TPC value and the 
AOC value was ~50 fold higher than reported 
previously. It is feasible that the choice solvent 
may be important because of difference in 
polarity influences the solubility of chemical 
components, extraction yield for antioxidants, 
TPC and AOC [26,27].  
 
All cytotoxicity testing used DMSO (<1. % final 
concentration) as solvent. This present study 
also adopted phenol red-free medium in order to 
avoid possible confounding effects from phenol 
red which possess estrogenic activity and AOC. 
Previous studies using MCF-7 cells with phenol 
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red present found the EC50 value for curcumin 
was 9.8 µM and 9.7 µM after 48 and 96-hours 
exposure, respectively [28]. Another study 
reported the curcumin EC50 value of 60µM for 
48-hour treatment [29]. More recent 
investigations found curcumin EC50 value with 
MCF-7 cells was, 31 µM, 21 µM or 11 µM when 
using 24, 48 or 72 -hours treatment, respectively 
[30]. Our previous study using MCF-7 cells in 
phenol red medium showed curcumin EC50 
value was 7 µM for 72-hour exposure [15] whilst 
in the present study curcumin E50 was 32.6 µM 
which is nearly 5-fold higher than observed 
previously.  
 
The number of reports dealing with the effect of 
ALA on MCF-7 cells is limited at present [15,31-
33]. There was a 55% inhibition of MCF-7 cells 
exposed to 75 µM ALA for 2 days in phenol red-
free medium [31] and treatment with 50 µM of 
ALA produced 33% inhibition [32]. In a previous 
study from our laboratory, the EC50 for ALA with 
3-days treatment in phenol red containing 
medium was 50 µM [15] which is significantly 
lower than the EC50 (117 µM ALA) from the 
present study; moreover, increasing the 
treatment time from 3 to 6 days led to a decline 
in EC50 to 62 µM (P = 0.0001). Some 
differences in EC50 may arise from differences in 
experimental details such as, initial number of 
cells in each well, length of time allowed for cells 
to adhere to microplates, and whether there are 
changes of culture medium during the treatment 
period. Interestingly, the range of doses for ALA 
inhibition of MCF-7 cells are thought to be 
attainable under physiological conditions [32] 
following dietary supplementation with PUFA 
when circulating plasma levels may reach 100-
200 µM [32]. 
 
The former design also did not allow 
isobolograms and CI analyses. In the present 
study, CI > 1.0 which is consistent with 
antagonism between ALA and curcumin. The 
current results are consistent with a drop in the 
potency for ALA or curcumin when used as a 
combination. In broad terms, a low value for 
EC50 (Table 2) is indicative of greater potency. 
The combination treatments produced 2.6-fold 
and 7.0-fold reductions of potency for ALA and 
curcumin, respectively. More extensive 
discussion of potency changes will require a 
wider range of studies over a wider range of 
concentrations 
 
In line with the initial working-hypothesis, the 
antagonisms between ALA and curcumin could 
arise from the tendency for ALA to undergo 
peroxidation and from the known antioxidant 
properties of curcumin [5,6] which would counter 
oxidative processes. In support of these views 
curcumin has been shown to reduce the 
effectiveness of conventional anti-cancer drugs 
which increase intracellular ROS [7]. Alternative 
models could emerge to account for such results. 
For example, it is known that ALA inhibits MCF-7 
cell growth via a range of mechanism, including 
the formation of ALA membrane phospholipids 
and alterations of growth and gene expression 
[5,31,33]. Curcumin also has multiple effects on 
cancer cells [8,9,28] and so other routes for 
antagonism could be possible. Interestingly, 
curcumin and docosahexaenoic acid were found 
interact antagonistically for several breast cancer 
cell phenotypes but synergistic in the case of 
another [34]. 
 
Intracellular ROS levels were increased in MCF-
7 after exposure to ALA, curcumin, and their 
combination for 1 hour using DCFH-DA assay. 
This finding (Fig. 5) is consistent with our working 
hypothesis, which is that ALA promotes 
intracellular ROS [12-15]. However, the 
intracellular ROS increases occurred at low 
concentrations (0.5 µM) of ALA and curcumin 
compared to those required to reduce cell 
viability (~32-100 µM; Table 2). Apparently, 
results from the DCFH-DA assay cannot be 
compared directly with cell viability results, 
maybe because of the difference in exposure 
period (1hr versus 3days). It was suggested that 
DCFH-DA assay may provide information related 
to stress within cells prior to injury [35]. 
 
This study was an in-vitro study with the usual 
limitations arising from the use of isolated cells. 
Since ALA appeared more effective with 
prolonged cell exposure then duration of 
combination studies could be extended. The 
intracellular ROS assays could also be easier to 
interpret if these used a longer study time. This 
paper extends previous reports that ALA and 
curcumin exhibit antagonism with respect of 
cytotoxicity in-vitro [15]. It is essential to examine 
such relations using a wider range of cancer cell 
types. Finally, the possible role of phenol red 
medium in cytotoxicity assays, particularly when 
using estrogen positive cells lines is also worthy 
of more in-depth investigations. 
 
5. CONCLUSION 
 
This study showed that curcumin has a higher 
content of TPC and AOC compared to turmeric. 
Both curcumin and ALA were cytotoxic towards 
MCF-7 cells. However, the combination of 
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curcumin and ALA reduced the effectiveness of 
each agent. Treatment of MCF-7 cells with ALA 
or curcumin produced significant increases of 
intracellular ROS but the former was 20-fold 
higher. The findings of this study suggest there 
are antagonistic interactions between ALA and 
curcumin with respect to their cytotoxicity 
towards MCF-7 breast cancer cells. Many 
conventional anticancer drugs are believed to 
function by increasing ROS and some of these 
were found to be antagonized by curcumin [7]. 
Caution is warranted because present results do 
not provide useful information about the effects 
of sequential treatments using curcumin and 
ALA.  It is also necessary to study the observed 
effects in animal models. With such reservations 
in mind, one implication of the present findings is 
that though dietary antioxidants could beneficial 
on their own there could be scope for 
antagonism with ALA, n-3 fatty acids, or other 
ROS dependent therapy [7]. There is an ongoing 
need to for more research into the effect other 
dietary antioxidants on anticancer agents. 
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